Official Report 329KB pdf
Agenda item 3 is for the committee to consider an update on cross-party groups. Members will note from the monitoring report the continued improvements in the overall level of compliance with the code. Since the monitoring report was issued, the cross-party group on life sciences has scheduled two meetings—an ordinary meeting on 11 June and an annual general meeting on 16 June—and the cross-party group on the middle east and south Asia has now submitted its annual return.
Does any member wish to comment on the report before us? In particular, do we wish to take any action on non-compliant groups? I am content, as convener, for that to be dealt with by the clerks, if that helps members to come to a conclusion.
I have a point of correction. The list of cross-party groups includes the psoriasis and psoriatic arthritis group, but the group has changed its name to the CPG on skin and associated rheumatic conditions. However, that might have happened after the date on which the report was completed, so that is fine.
Okay. That is a technical change, which we are quite happy with.
Are we otherwise content with the report?
Members indicated agreement.